TFX · NYSE · STOCK
Teleflex (TFX) Stock Analysis
$128.06
52W $100.18 – $145.00
52/100
$5.71B
-5.5
0.81
Is TFX Bullish or Bearish?
Mixed.
Innellis AI committee rates Teleflex Incorporated (TFX) Watch with a composite score of 52/100
, based on 5 analysts with 40% agreement.
Last updated September 17, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +7.56 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -12.44 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.27 across 11 articles, 14d). Technical Analyst remains cautious — rsi at 21 is in oversold territory (could mean either capitulation or a bounce setup). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- News sentiment is positive (+0.27 across 11 articles, 14d) — News
Bear Case
- ROE of only -31.9% -- cheap may mean cheap for a reason — Value
- Revenue declining -14.5% YoY -- this is not a growth story right now — Growth
- RSI at 21 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of September 17, 2026
Overall Committee Score
52/100
Agreement
40%
Analysts
5
Conviction
Contested
Sector Rank
Top 85%
of 192 Healthcare peers
Value Analyst
neutral
42
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− ROE of only -31.9% -- cheap may mean cheap for a reason
Growth Analyst
neutral
50
/ 100 · Moderate confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− Revenue declining -14.5% YoY -- this is not a growth story right now
Technical Analyst
bearish
38
/ 100 · High confidence
Price action is deteriorating -- trend and/or momentum are working against this name
− RSI at 21 is in oversold territory (could mean either capitulation or a bounce setup)
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
66
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 11 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2514.55)
Investment Thesis Evolution
Committee score moved marginally from 52.4 to 52.4.
Comparing 2026-09-16 to 2026-09-17 (1 day apart).
Technical Analysis
RSI (14)
21.1
Oversold
MACD Histogram
-1.336
Bearish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$121.22
Resistance
$133.13
Bollinger %B
0.02
Inside Bands
Price vs Moving Averages
EMA 9
$133.57
Below
EMA 21
$135.41
Below
EMA 50
$134.70
Below
EMA 200
$128.63
Below
Fundamental Analysis
Valuation
98
Growth
66
Profitability
21
Financial Health
88
Cash Flow
70
Valuation
P/E Ratio
-5.5×
P/B Ratio
1.94×
PEG Ratio
-0.29
Dividend Yield
1.05%
52W High
$145.00
52W Low
$100.18
Quality & Growth
ROE
-2898.3%
ROA
-1303.6%
Gross Margin
5376.5%
Operating Margin
334.9%
Revenue Growth YoY
—
Debt / Equity
0.99
AI Fundamental Assessment
P/E ratio of -5.5 (inexpensive relative to a 15-40x range); Price-to-book of 1.9x; PEG ratio of -0.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -29.0%; Return on assets of -13.0%; Net margin of -39.6%; Gross margin of 53.8%; Current ratio of 2.60 (healthy short-term liquidity); Debt-to-equity of 0.99; Free cash flow per share is positive (8.97); Most recent quarter beat estimates by 36.0%; 2 consecutive earnings beats; EPS growth accelerating (-28.0% -> +26.6% QoQ); Analyst estimates falling over recent quarters
Get the Full TFX Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →